Titolo | Pubblicato in | Anno |
---|---|---|
Eltrombopag for treatment of thrombocytopenia-associated disorders | EXPERT OPINION ON PHARMACOTHERAPY | 2015 |
Will post-transplantation cell therapies for pediatric patients become standard of care? | BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2015 |
ADARs and the balance game between virus infection and innate immune cell response | CURRENT ISSUES IN MOLECULAR BIOLOGY | 2015 |
Erratum: Outcome of children with high-risk acute myeloid leukemia given autologous or allogeneic hematopoietic cell transplantation in the AIEOP AML-2002/01 study | BONE MARROW TRANSPLANTATION | 2015 |
Bone marrow immunophenotyping by flow cytometry in refractory cytopenia of childhood | HAEMATOLOGICA | 2015 |
Collaborative efforts driving progress in pediatric acute myeloid leukemia | JOURNAL OF CLINICAL ONCOLOGY | 2015 |
Erratum: Eltrombopag for children with chronic immune thrombocytopenia (PETIT2): A randomised, multicentre, placebo-controlled trial (Lancet (2015) 386 (1649-1658) | THE LANCET | 2015 |
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma